- Home
- NARI
NARI
Inari Medical Inc.
as 11-22-2024 4:00pm EST
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 3.0B | IPO Year: | 2020 |
| Target Price: | $59.13 | AVG Volume (30 days): | 918.3K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $36.73 - $67.13 | Next Earning Date: | 10-28-2024 |
| Revenue: | $574,498,000 | Revenue Growth: | 22.41% |
| Revenue Growth (this year): | 24.59% | Revenue Growth (next year): | 18.28% |
Stock Insider Trading Activity of Inari Medical Inc. (NARI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hoffman William | NARI | Director | Nov 18 '24 | Sell | $51.06 | 60,000 | $3,069,520.64 | 524,449 | |
| Hoffman William | NARI | Director | Oct 29 '24 | Sell | $50.05 | 40,000 | $2,002,000.00 | 524,449 | |
| Hykes Andrew | NARI | President and CEO | Oct 29 '24 | Sell | $50.00 | 3,000 | $150,000.00 | 445,310 | |
| Hoffman William | NARI | Director | Oct 16 '24 | Sell | $45.18 | 40,000 | $1,800,834.84 | 524,449 | |
| Hoffman William | NARI | Director | Sep 16 '24 | Sell | $46.00 | 40,000 | $1,833,188.44 | 524,449 | |
| Hill, Mitch C. | NARI | Chief Financial Officer | Sep 12 '24 | Sell | $45.51 | 3,000 | $135,385.22 | 180,991 |
Latest Inari Medical Inc. News
NARI Breaking Stock News: Dive into NARI Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Inari Medical Insider Sold Shares Worth $3,069,521, According to a Recent SEC Filing
Yahoo Finance
6 days ago
Inside a $400 billion bet on the brain-computer interface revolution
Argus Research
11 days ago
NARI: Raising target price to $41.00
Insider Monkey
17 days ago
Is Inari Medical (NARI) Trading at an Attractive Valuation?
GlobeNewswire
17 days ago
Inari Medical to Participate in the Jefferies London Healthcare Conference
Argus Research
18 days ago
NARI: Raising target price to $40.00
MT Newswires
23 days ago
Inari Medical Insider Sold Shares Worth $2,002,000, According to a Recent SEC Filing
MedTech Dive
24 days ago
Edwards, Medtronic and Inari share trial data at TCT conference
Compare NARI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NARI Inari Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.